Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.

× No keyword cloud information.

27 in total

1. CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.

Authors: K Schieweck; J Stanek; P M Kanter; K H Schmidt-Ruppin; M Müller; A Matter
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.

Authors: D Godenèche; J C Madelmont; M F Moreau; R Plagne; G Meyniel
Journal: Cancer Chemother Pharmacol Date: 1980 Impact factor: 3.333

3. Pharmacokinetics of 11C-BCNU in experimental brain tumor.

Authors: K Sako; M Diksic; S Farrokhzad; Y L Yamamoto; W Feindel
Journal: J Neurooncol Date: 1985 Impact factor: 4.130

Review 4. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.

Authors: S Amarasingh; M R Macleod; I R Whittle
Journal: J Neurooncol Date: 2008-09-24 Impact factor: 4.130

5. Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.

Authors: R H Earhart; F M Muggia; F M Golomb
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

6. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

Authors: L G Feun; D J Stewart; M E Leavens; M A Burgess; N Savaraj; R S Benjamin; G P Bodey
Journal: J Neurooncol Date: 1983 Impact factor: 4.130

7. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.

Authors: B Drewinko; L Y Yang
Journal: Invest New Drugs Date: 1983 Impact factor: 3.850

8. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.

Authors: V A Levin; P A Kabra; M A Freeman-Dove
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

9. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.

Authors: L C Panasci; D Green; P S Schein
Journal: J Clin Invest Date: 1979-10 Impact factor: 14.808

10. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Authors: E M Hiesiger; S B Green; W R Shapiro; P C Burger; R G Selker; M S Mahaley; J Ransohoff; J C VanGilder; J Mealey; J T Robertson
Journal: J Neurooncol Date: 1995 Impact factor: 4.130